Personalized Multi-peptide Vaccination in Combination With the TLR1/2 Ligand XS15 in Cancer Patients
The aim of this project is to provide personalized multi-peptide vaccination in combination with the TLR1/2 ligand XS15 to individual patients with advanced solid and hematological malignancies without any approved treatment options.
Cancer
BIOLOGICAL: Personalized multi-peptide vaccine
Ethics: Patient treatment will be conducted according to ยง13 Absatz 2b, AMG.